Results 91 to 100 of about 54,861 (297)

Dosing Interval Extension of Dupilumab in CRSwNP: Five‐Year Real World Outcomes

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is a persistent, often Type 2‐mediated inflammatory disease that markedly impairs quality of life. While dupilumab provides rapid improvement, there is limited evidence on long‐term outcomes beyond 2 years, and the clinical impact of dosing‐interval extension remains unclear.
Nicholas J. Campion, Dioni‐Pinelopi Petsiou, Florian C. Fally, Karina Berbalk, Noah F. Melamed, Aldine Tu, Christina Morgenstern, Fana Alem Kidane, Mohammed Zghaebi, Linda Liu, Minghao Pan, Tina J. Bartosik, Victoria Stanek, Katarina Gangl, Julia Eckl‐Dorna, Sven Schneider   +15 more
wiley   +1 more source

Olfactory dysfunction in Parkinson’s disease: Benefits of quantitative odorant examination

, 2010
Yuji Kawase1, Kazuko Hasegawa2, Noriko Kawashima3, Emiko Horiuchi2, Ken Ikeda11Department of Neurology, Toho University Omori Medical Center, Tokyo; 2Department of Neurology, Sagamihara National Hospital, Kanagawa; 3Kawashima Neurology Clinic, Kanagawa ...
Yuji Kawase, Kazuko Hasegawa, et al, Noriko Kawashima   +3 more
core  

Olfactory Bulb Volume Reflects Olfactory Dysfunction and Network Organization: Insights From the Population‐Based Rhineland Study

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Olfactory dysfunction is common in aging and an early symptom of neurodegenerative diseases, but how structural (olfactory bulb [OB] volume) and functional (olfactory network [OFN] functional connectivity [FC]) brain features interact to shape odor identification ability remains unclear.
Weiyi Zeng, Konstantinos Melas, Santiago Estrada, N. Ahmad Aziz, Monique M. B. Breteler   +4 more
wiley   +1 more source

Association between duration or intensity of tobacco smoking and olfactory function: A cross-sectional study among smokers willing to quit smoking

Tobacco Induced Diseases
Introduction range of studies suggests that people who smoke tobacco have impaired olfactory function, but few have explored the association between smoking history, such as duration or intensity, and olfactory function.
Cornelia Wälchli, Valerie Grünig, Kali Tal, Nicolas Rodondi, Ivan Berlin, Jean-Paul Humair, Anja Frei, Susanne Pohle, Julian Jakob, Reto Auer, Sophia C. Poletti, Anna Schoeni   +11 more
doaj   +1 more source

Determining the Minimal Clinically Important Difference of the 40‐Item Smell Identification Test in People With Cystic Fibrosis

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis (CRS) and olfactory dysfunction (OD) are highly prevalent among people with cystic fibrosis (PwCF) and negatively impact quality of life. The 40‐item Smell Identification Test (SIT) is widely used to assess psychophysical olfaction, but a CF‐specific minimal clinically important difference (MCID) has not been ...
Eugene Oh, Jessa E. Miller, Michelle J. Lee, Anna Zemke, David Baraghoshi, Matthew J. Strand, Jeremiah A. Alt, Todd E. Bodner, Michael Chang, Naweed I. Chowdhury, Patricia H. Eshaghian, Anne E. Getz, Jennifer L. Goralski, David A. Gudis, Peter H. Hwang, Ashoke Khanwalkar, Adam J. Kimple, Jivianne T. Lee, Douglas A. Li, Jess C. Mace, Jayakar V. Nayak, Jonathan B. Overdevest, Zara Patel, Daniella K. Safatian, Rodney J. Schlosser, Brent Senior, Amanda L. Stapleton, Timothy L. Smith, Zachary M. Soler, Jeffrey D. Suh, Grant A. Turner, Marilene B. Wang, Milene T. Saavedra, Jennifer L. Taylor‐Cousar, Daniel M. Beswick   +34 more
wiley   +1 more source

Metabolic syndrome, olfactory dysfunction, and brain morphology [PDF]

, 2019
Both metabolic syndrome (MetS) and olfactory dysfunction are highly prevalent disorders, and closely related to brain function. Although several studies implied a link between several components of MetS and olfactory dysfunction, it remains unclear how ...
Lu, Ran
core  

Subjective loss of smell and taste and psychophysical olfactory dysfunction and gustatory dysfunction assessment.

, 2022
Subjective loss of smell and taste and psychophysical olfactory dysfunction and gustatory dysfunction assessment.
Kasper Daugaard Larsen (13899442), Preben Homøe (2219161), Anders Lykkemark Simonsen (10778909), Anne-Sophie Homøe (13899445), Tobias Todsen (384337), Grethe Badsberg Samuelsen (13899448), Xiaohui Chen Nielsen (13899451), Elisabeth Arndal (9610183), Anders Koch (2219158), Mads Mose Jensen (13899439)   +9 more
core   +1 more source

Extent of Sinus Surgery Is Associated With Disease Control in Biologic Treated Type 2 Dominant CRS

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background A greater benefit of biologics is observed after surgery in Type 2 chronic rhinosinusitis with nasal polyps (CRSwNP). However, the extent of surgery remains undefined in many studies. This study evaluated the extent of surgery on disease control in patients receiving biologics for refractory Type 2 dominant CRSwNP.
Nicholas J. Campion, Peta‐Lee Sacks, Lu Hui Png, Ruoxin Hua, Rhea Darbari Kaul, Raquel Alvarado, Christine Choy, Raymond Sacks, Peter Earls, Raewyn G. Campbell, Larry Kalish, Richard J. Harvey   +11 more
wiley   +1 more source

Role and Mechanism of Olfactory Stem Cells in the Treatment of Olfactory Disorders

Stem Cells International
Olfactory dysfunction is one of the most prevalent diseases in otorhinolaryngology, particularly since the coronavirus 2019 (COVID-19) pandemic, with a potential impact on daily life.
Shengqi Gan, Siyuan Qu, Hai Zhu, Mengdan Gong, Yizhen Xiang, Dong Ye   +5 more
doaj   +1 more source

Lost and Found: Is Olfactory Recovery More Promising After COVID‐19 Than Other Causes, Even 2 Years Later?

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Olfactory dysfunction is a hallmark feature of COVID‐19, yet the potential for recovery with long‐standing COVID‐19‐related smell loss (CRSL) remains uncertain, particularly when treatment is initiated years later. This study evaluated olfactory outcomes in patients with CRSL compared with non‐COVID‐19‐related smell loss (non‐CRSL),
John W. Hunsicker, Mabel Berg, Nicolaus Knight, Jessica W. Grayson, Bradford A. Woodworth, Justin H. Turner, Do‐Yeon Cho   +6 more
wiley   +1 more source